In , Neogen Chemicals Ltd (Speciality Chemicals) is outperforming Nifty 500 with +48.4% relative strength. Fundamentals: Average. On a 9-week streak.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Based on Q3 FY26 earnings • Updated Apr 19, 2026
What: PPAP Approval: Completed
“We have already achieved a major milestone by securing long-term commercial supply approval from a prominent giga-scale Indian manufacturer following successful PPAP completion.”
What: Capacity Utilisation: 80% target for salt
Impact: ₹1,000 crore+ revenue
“one thing which looks very strong to me is that our salt capacity should be utilized at 80% or more.”
What: US 45X Tax Credits: Non-FEOC requirement
“This requires a complete transition to non-FEOC suppliers by 2027 for electrolyte salt.”
What: Chairman/MD Separation: Effective Oct 1, 2025
“The board has approved the separation of the roles of Chairman and Managing Director, effective October 1, 2025.”
What: Insurance/Equity Inflow: ₹550 crore
“So we expect around INR 550 crore to come either in this year or in Q1 next year.”
What: Inorganic segment growth of 35%
“our inorganic chemical segment showed even stronger momentum, delivering INR 33 crore in revenue, a 35% growth compared to the same period last year.”
Earnings deceleration risks from management commentary
Trigger: Lithium prices started increasing in late 2025, which will impact costs in early 2026.
Management view: Targeting 20% ROCE to manage margin volatility.
Monitor: commodity
Trigger: China announced restrictions on November 8th, which shook up customers.
Management view: Positioning as a non-FEOC alternative with Japanese technology.
Monitor: geopolitical
Trigger: Approval cycles are long and dependent on customer visit schedules.
Management view: Building inventory to ensure supply continuity during ramp-up.
Monitor: regulatory
Key quotes from recent conference calls
“So depending on how electrolyte demand comes up in the Q4, we expect it to be in the range of around INR 30 crore to INR 40 crore for the current year. [Previous Battery Chemicals Revenue FY26 guidance]”
“Notably, this establishment is India's only non-FEOC compliant electrolyte salt plant with proven established technology. [Initiative: Neogen Morita New Materials JV]”
“EBITDA margin, it is very difficult to predict because of lithium price volatility. [Risk (commodity): MEDIUM]”
“One of the biggest help China did to market our product is the restrictions they announced from 8th November. [Risk (geopolitical): MEDIUM]”
Headline numbers from the latest earnings call
Revenue
₹220 crore
Why: Growth was led by higher volume across both organic and inorganic chemical segments reflecting steady market demand despite capacity bottlenecks.
Revenue growth was resilient despite the unavailability of the Dahej facility, supported by toll manufacturing arrangements.
EBITDA
₹32 crore
Why: Performance was impacted by operational overheads as Neogen Ionics scales up and additional interim toll manufacturing expenses during plant reconstruction.
EBITDA margins were pressured by transitionary costs related to the fire incident and new business ramp-up.
PAT
₹4 crore
Why: Profitability was constrained by increased interest expenses related to Dahej capital expenditure and front-loaded expenditures at Neogen Ionics.
PAT remains low due to high finance costs and initial costs of the battery chemicals subsidiary.
Other Highlights
• Inorganic chemical segment delivered 35% growth reaching ₹33 crore in revenue.
• Net claim receivable for the fire incident stands at ₹251.12 crore.
• Board approved raising up to ₹150 crore via preferential issue to the Promoter Group.
Sub-sector-specific signals from the latest concall — each with management's stated reason for the change
Electrolyte Salt Capacity (LiPF6)
5,500 MT
Why: Total planned capacity across Dahej and Pakhajan sites.
Target Salt Capacity Utilisation
80%
Why: Standard utilization target for a chemical plant setup.
Inventory Days Target
140 to 160 days
Why: Targeting this level once full utilization is reached in the next financial year.
Debtor Days Target
60 to 90 days
Why: Standard range based on mix of international and domestic sales.
Consolidated Net Debt
₹1,175 crore
Why: Increase due to NCD issuance and ongoing capex for plant rebuilding.
Target Consolidated Gross Block
₹2,000 crore
Why: Expected gross block once all current projects are completed by FY27.
Neogen Ionics Target ROCE
20%
Why: Management's stable-state return target for the battery chemicals business.
CSM Business Contribution
16%
Why: Contribution reached this level despite the fire incident at Dahej.
Forward-looking targets from management for FY27
OPM Guidance
18%
Capex Plan
₹1500 Cr
₹400 crore to ₹500 crore from battery chemicals in FY27
REAFFIRMED
₹1,500 crore
Total investment across Dahej and Pakhajan sites
REAFFIRMED
Guidance Changes
Dahej 1,100 ton capacity commissioning: December 2025 → March 2026
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +22% | +8% | Accelerating |
| PAT (Net Profit) | +450% | -17% | Inflection Up |
| OPM | 18.0% | 0 bps | Volatile |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 19, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Neogen Chemicals Ltd's latest quarterly results (Mar 2026) show
Neogen Chemicals Ltd's profit is growing with an turning around (inflection up) trend.
Neogen Chemicals Ltd's revenue growth trend is accelerating.
Neogen Chemicals Ltd's operating margin is volatile.
Neogen Chemicals Ltd's long-term compounding rates
Neogen Chemicals Ltd's earnings growth is turning around (inflection up) with improving on a sequential basis.
Neogen Chemicals Ltd's trailing twelve month (TTM) performance
Neogen Chemicals Ltd appears significantly overvalued based on our fair value analysis.
Neogen Chemicals Ltd's current PE ratio is 179.0x.
Neogen Chemicals Ltd's current PE is 179.0x.
Neogen Chemicals Ltd's price-to-book ratio is 6.1x.
Neogen Chemicals Ltd is rated Average with a fundamental score of 41.24/100. This score is calculated from objective financial metrics
Neogen Chemicals Ltd has a debt-to-equity ratio of N/A.
Neogen Chemicals Ltd's return ratios over recent years
Neogen Chemicals Ltd's operating cash flow is negative (FY2026).
Neogen Chemicals Ltd's current dividend yield is 0.05%.
Neogen Chemicals Ltd's shareholding pattern (Apr 2026)
Neogen Chemicals Ltd's promoter holding has increased recently.
Neogen Chemicals Ltd has been outperforming Nifty 500 for 9 consecutive weeks, indicating consistent outperformance.
Neogen Chemicals Ltd is an established outperformer with 9 weeks of consecutive Nifty 500 outperformance.
Neogen Chemicals Ltd has 6 key growth catalysts identified from recent earnings analysis
Neogen Chemicals Ltd has 3 key risks worth monitoring
In Q3 FY26, Neogen Chemicals Ltd's management highlighted
Neogen Chemicals Ltd's management has provided the following forward guidance for FY27
Neogen Chemicals Ltd's most important sub-sector-specific KPIs from the latest concall
Based on quantitative research signals, here is why Neogen Chemicals Ltd may be worth studying
Neogen Chemicals Ltd investment thesis summary:
Neogen Chemicals Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
